HIGHLIGHTS
- who: Kutlwano R. Xulu and Tanya N. Augustine from the School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, York Road, Parktown, Johannesburg, South Africa have published the research: Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs, in the Journal: Pharmaceuticals 2022, 15, 1532. of /2022/
- what: The authors explore the molecular mechanisms of selected anticoagulant/antiplatelet drugs specifically on platelet activation pathways and the implications for tumour progression that can be described as a tumour`s capacity for survival and metastasis.
- future: It is increasingly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.